← Back to headlines

ImmunityBio Stock Has Jumped 230% in a Year: How Anktiva’s 431% Sales Surge Is Driving IBRX

This story is reported by TIKR.com. Read what other outlets are saying below, then open the original report for full details.

ImmunityBio Stock Has Jumped 230% in a Year: How Anktiva’s 431% Sales Surge Is Driving IBRX · NabkaNews